1/32
Comprehensive vocabulary flashcards covering the classes, mechanisms of action, clinical indications, adverse effects, and special monitoring requirements of psychotropic medications.
Anxiolytics
A class of medications used to treat manifestations of anxiety.
Benzodiazepines
Schedule IV controlled substances that act as CNS depressants by regulating the function of GABA; they cause large dopamine release from the limbic system, increasing physical dependence potential.
Alprazolam (Xanax)
An oral-only benzodiazepine indicated for anxiety that features an intermediate onset of action and short duration.
Clonazepam (Klonopin)
An oral-only benzodiazepine indicated for anxiety that features a slow onset and longer duration of action.
Chlordiazepoxide (Librium)
A benzodiazepine indicated for anxiety and alcohol withdrawal with intermediate onset and long duration; administered orally, IM, or IV.
Diazepam (Valium)
A fast-onset, longer-duration benzodiazepine indicated for anxiety, alcohol withdrawal, and muscle relaxation; administered via oral, IM, IV, or rectal routes.
Lorazepam (Ativan)
A benzodiazepine indicated for anxiety and alcohol withdrawal with an intermediate onset and intermediate duration; administered orally, IM, or IV.
Buspirone (Buspar)
A partial agonist of the 5-HT receptor indicated for generalized anxiety disorder (GAD); has a delayed onset and causes side effects like sedation, nausea, dizziness, headache, and restlessness.
Hydroxyzine (Vistaril)
An antihistamine indicated for mild anxiety; side effects include drowsiness, dizziness, dry mouth, and constipation.
Propranolol (Inderal)
A beta blocker indicated for performance anxiety that targets somatic symptoms; side effects include decreased blood pressure, decreased heart rate, and orthostatic hypotension.
Clonidine (Catapres)
An alpha 2 receptor agonist indicated for the treatment of acute symptoms during withdrawal.
SSRIs (Selective Serotonin Reuptake Inhibitors)
First-line antidepressants that work by selectively blocking serotonin reuptake at presynaptic receptors.
Serotonin Syndrome
A medical emergency characterized by restlessness, dilated pupils, tachycardia, hyperpyrexia, muscle rigidity, sweating, and loss of muscle coordination; treated with cyproheptadine.
SNRIs (Serotonin Norepinephrine Reuptake Inhibitors)
Medications that block the reuptake of both serotonin and norepinephrine at presynaptic receptors; frequently effective for anxiety and chronic pain, with side effects including appetite suppression and weight loss.
TCAs (Tricyclic Antidepressants)
Antidepressants that block the presynaptic reuptake of serotonin and norepinephrine; associated with worse anticholinergic effects including dry mouth, constipation, urinary retention, and orthostatic hypotension.
MAOIs (Monoamine Oxidase Inhibitors)
Antidepressants that inhibit the enzyme monoamine oxidase from breaking down monoamine neurotransmitters; require dietary avoidance of tyramine to avoid hypertensive crisis.
Bupropion (Wellbutrin)
An atypical antidepressant used for depression (especially with low motivation); lowers the seizure threshold and can worsen anxiety in some patients.
Mirtazapine (Remeron)
A sedating atypical antidepressant indicated for depression and anxiety that can be utilized to promote sleep and increase appetite.
Trazodone
An atypical medication commonly used for sleep and depression; patients must be monitored for and report sustained penile erection.
Lithium
A mood stabilizer indicated for bipolar disorder mania with a normal therapeutic range of 0.6–1.2; requires monitoring salt intake, thyroid and kidney function, and fluid intake of 2–3liters per day.
Kindling Process
A neurological process with an unknown link to mania that anticonvulsant mood stabilizers are hypothesized to inhibit.
Valproic Acid / Valproate (Depakote)
An anticonvulsant mood stabilizer that increases GABA levels to treat bipolar mania; carries warnings for birth defects, blood dyscrasias, and elevated liver function risk.
Carbamazepine (Tegretol)
An anticonvulsant indicated for irritable and aggressive bipolar states; requires monitoring for reduced blood counts (blood dyscrasias), hyponatremia, and severe rash within the initial weeks.
Lamotrigine (Lamictal)
An anticonvulsant useful for bipolar depression (less helpful for mania); carries a prominent risk of severe rash within the first few weeks and Stevens-Johnson Syndrome.
First-Generation Antipsychotics (FGAs / Typical)
Very potent neuroleptics that treat mania and severe psychosis by blocking dopamine receptors; carry higher risks for extrapyramidal symptoms (EPS) and neuroleptic malignant syndrome.
Haloperidol (Haldol)
A typical first-generation antipsychotic administered via injection and used more often than other FGAs for severe psychosis; carries a strong association with extrapyramidal symptoms.
Neuroleptic Malignant Syndrome (NMS)
A life-threatening medical emergency caused by antipsychotics, presenting with high fever and muscle stiffness.
Extrapyramidal Symptoms (EPS)
Movement disorders caused by dopamine-blocking antipsychotics, including dystonia (sustained muscle contractions), sialorrhea (drooling), Parkinsonian symptoms, and potentially irreversible tardive dyskinesias.
Second-Generation Antipsychotics (SGAs / Atypical)
Antipsychotics that block dopamine receptors to a lesser degree than FGAs and inhibit serotonin reuptake; generally carry a lower risk for EPS.
Aripiprazole (Abilify)
A second/third-generation antipsychotic (dopamine stabilizer) with lower EPS risk, approved for psychosis, bipolar disorder, severe depression adjunct, and pediatric use; can cause new impulse control problems.
Clozapine (Clozaril)
A second-generation antipsychotic for psychosis and bipolar disorder associated with a high risk of blood dyscrasias, mandating weekly lab draws.
Cariprazine (Vraylar)
A second-generation antipsychotic indicated for psychosis and bipolar disorder that specifically helps improve negative symptoms.
Pimavanserin (Nuplazid)
A second-generation atypical antipsychotic indicated specifically for treating hallucinations associated with Parkinson's disease.